Clinical Trial Update: Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tocilizumab for acute anterior ischemic optic neuropathy related to giant cell arteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Optic Ischaemic Neuropathy

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | Conditions: Giant Cell Arteritis, Optic Ischaemic Neuropathy | Phase 2 | Status: UNKNOWN